9 Results for "

isothermal calorimetry

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "isothermal calorimetry" in MCE Product Catalog:

Cat. No.: HY-N2054
CAS No.: 52222-74-9
Synonyms: Kaempferol 4'-β-glucoside
Kaempferol 4'-glucoside (Kaempferol 4'-β-glucoside) is a glycosylated form of Kaempferol (HY-14590). Kaempferol 4'-glucoside interacts with SBE-β-CD (HY-17031). Kaempferol 4'-glucoside can be used in the food and active compound industries .
loading...
    loading...
Cat. No.: HY-175303
CAS No.: 185522-92-3
Target:  

Xanthine Oxidase

Research Areas:  

Metabolic Disease

Xanthine oxidase-IN-17 is a potent xanthine oxidase (XOD) inhibitor with an IC50 of 298 nM and a Ki of 167 nM. Xanthine oxidase-IN-17 decreases the formation of O radical by inhibiting the catalytic activity of XOD to diminish the production of uric acid. Xanthine oxidase-IN-17 shows no cytotoxicity in AML-12 hepatocytes, while suppressing uric acid production. Xanthine oxidase-IN-17 can be used for the studies of hyperuricemia and subsequently to gout .
loading...
    loading...
Cat. No.: HY-136257
CAS No.: 2244684-50-0
Purity:  99.72%
Target:  

PROTACs

Research Areas:  

Others

CMP98 is a homologous PROTAC that serves as a negative control compound for CM11, a pVHL30 PROTAC degrader. CMP98 does not induce VHL protein degradation, bind to the VCB complex, or form a ternary VCB complex .
loading...
    loading...
Cat. No.: HY-168536
CAS No.: 3086104-39-1
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

SJ46411 is a potent ligand for KLHDC2, with a Kd of ~260 nM measured by isothermal titration calorimetry (SPR Kd = 0.5 μM, TR-FRET IC50 = 3.9 μM, ΔTm = 6.0 °C) .
loading...
    loading...
Cat. No.: HY-174842
CAS No.: 696643-14-8
HTS05585 (Compound Hit-1) is a selective macrophage migration inhibitory factor (MIF) inhibitor with a Kd value of 0.29 μM measured by microscale thermophoresis (MST) and 0.32±0.01 μM verified by isothermal titration calorimetry (ITC). HTS05585 inhibits the release of pro-inflammatory factors (TNF-α, IL-6, IL-1β) from LPS-induced macrophages. HTS05585 is promising for research of inflammation-related diseases such as sepsis .
loading...
    loading...
Cat. No.: HY-P11145
CAS No.: 216876-10-7
Target:  

Influenza Virus

Research Areas:  

Infection Inflammation/Immunology

Influenza HA (529-537) is the amino acid sequence (IYATVAGSL) at positions 529-537 of the hemagglutinin (HA) of the influenza A virus. Influenza HA (529-537) can be recognized by three different specificities (H1-specific, H2-specific, H1/H2 cross-reactive) of CD8 + cytotoxic T-lymphocyte (CTL) clones. Influenza HA (529-537) can be used to understand T-cell immune specificity and to design new vaccines .
loading...
    loading...
Cat. No.: HY-P11167
CAS No.: 1346415-30-2
Target:  

Inhibitory Antibodies

Research Areas:  

Infection

Decapeptide DP1 is an artificially designed peptide of ten amino acids (DEHGTAVMLK). Decapeptide DP1 mimics the organic ligand components found in the natural Mn²⁺ antioxidant complex and is used to construct the highly effective radiation protection agent MDP (Mn²⁺-DP1-Pi complex) .
loading...
    loading...
Cat. No.: HY-182033
CAS No.: 2761081-10-9
Target:  

Bacterial ClpP

Research Areas:  

Infection

ClpP agonist 1 is a Staphylococcus aureus ClpP (SaClpP) agonist with an EC50 of 1.44 μM, Kd values of 2.95 μM (isothermal titration calorimetry) and 18 μM (bio-layer interferometry), and a low drug resistance frequency. ClpP agonist 1 reduces bacterial load, shrinks infected area and improves histopathological outcomes in a mouse skin infection model. ClpP agonist 1 can be used for the research of Methicillin (HY-121544)-resistant Staphylococcus aureus (MRSA) skin infections .
loading...
    loading...
Cat. No.: HY-185217
CAS No.: 2429876-60-6
Target:  

Ras

Research Areas:  

Cancer

PPI stabilizer-1-1 (Compound 2) is a KRAS dimerizing agent. PPI stabilizer-1-1 dimerizes KRAS with a KD of 3.8 µM. PPI stabilizer-1-1 co-crystallizes with GCP-KRAS G12D. PPI stabilizer-1 can be used for the research of KRAS-driven cancers .
loading...
    loading...